PepGen Revenue and Competitors
Estimated Revenue & Valuation
- PepGen's estimated annual revenue is currently $16.9M per year.
- PepGen's estimated revenue per employee is $155,000
Employee Data
- PepGen has 109 Employees.
- PepGen grew their employee count by 22% last year.
PepGen's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | VP, Bioanalytical, Biomarkers and DMPK | Reveal Email/Phone |
5 | Head Corporate Strategy and Business Development | Reveal Email/Phone |
6 | VP, Global Regulatory Affairs | Reveal Email/Phone |
7 | VP, Quality Assurance | Reveal Email/Phone |
8 | VP, Finance & Controller | Reveal Email/Phone |
9 | SVP Chemistry & Manufacturing | Reveal Email/Phone |
10 | VP, Toxicology | Reveal Email/Phone |
PepGen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is PepGen?
N/A
Total Funding
109
Number of Employees
$16.9M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PepGen News
2022-04-17 - PepGen Targets IPO For Duchenne Muscular Dystrophy Treatments
PepGen has filed to raise funding via a U.S. IPO. The firm is developing treatment candidates for Duchenne Muscular Dystrophy and related...
2022-03-30 - PepGen Announces First Participant Dosed in a Phase 1 ...
PepGen Announces First Participant Dosed in a Phase 1 Clinical Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy.
2022-03-22 - PepGen Continues to Build Leadership Team with Additions ...
BOSTON, March 30, 2022 (GLOBE NEWSWIRE) -- PepGen, Inc., advancing the next generation of oligonucleotide therapies with the goal of...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 109 | 31% | N/A |
#2 | $27.6M | 109 | 12% | N/A |
#3 | $19.6M | 109 | 6% | N/A |
#4 | $29.4M | 109 | 9% | N/A |
#5 | $16.4M | 109 | 2% | N/A |